RGL-305+ Lymphoma + Exploratory Clinical Study

Clinical trial NCT07006012 · RECRUITING

Trial details

NCT number: NCT07006012
Sponsor: Fudan University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)

Start date: 2025-04-21
Primary completion: 2028-03-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.